
Amolyt Pharma
Multinational group of biopharmaceutical companies developing drugs, proteins and peptides.
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
* | $800m | Acquisition | |
Total Funding | 000k |

Bpifrance(exited)

Crédit Agricole Île-de-France(exited)

Millendo Therapeutics(exited)

EQT Life Sciences(exited)

Sectoral Asset Management(exited)

Andera Partners(exited)

Sofinnova Partners(exited)

Intermediate Capital Group(exited)

Turenne Capital(exited)

Pontifax Funds(exited)

ATEM Capital(exited)

Mass General Brigham Ventures(exited)

OrbiMed(exited)

Novo Holdings(exited)

Kurma Partners(exited)

Eurazeo(exited)

Tekla Capital Management(exited)

CTI Life Sciences(exited)
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | - | - | 155 % | (47 %) |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (24165 %) | - | - | (91857 %) | (107800 %) | (327471 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.